首页 产品目录 分子砌块 按反应类型 五元杂环胺化 1-环丙基-6-氟-8-甲氧基-7-(3-甲基哌嗪-1-鎓-1-基)-4-氧代-1,4-二氢喹啉-3-羧酸盐

1-环丙基-6-氟-8-甲氧基-7-(3-甲基哌嗪-1-鎓-1-基)-4-氧代-1,4-二氢喹啉-3-羧酸盐

1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

160738-57-8

中文名称

1-环丙基-6-氟-8-甲氧基-7-(3-甲基哌嗪-1-鎓-1-基)-4-氧代-1,4-二氢喹啉-3-羧酸盐

英文名称

1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate

别名

AMY17807 | NCGC00247879-01 | s5964 | 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid hydrochloride | AM-1155 hydrochloride;CG5501 hydrochloride;BMS-206584 hydrochloride;PD135432 hydrochloride | gatifloxacin hyd

标准英文名

1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate

分子式

C19H22FN3O4

分子量

375.40

精确分子量

375.16

SMILES

COC1=C2C(=CC(F)=C1N1CC[NH2+]C(C)C1)C(=O)C(C(=O)[O-])=CN2C1CC1

标准SMILES

CC1CN(CC[NH2+]1)C1=C(F)C=C2C(=C1OC)N(C=C(C([O-])=O)C2=O)C1CC1

用途

Gatifloxacin hydrochloride is a fourth-generation broad-spectrum fluoroquinolone antibiotic used clinically for the treatment of moderate to severe infections caused by susceptible strains, including: (1) acute exacerbations of chronic bronchitis due to Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, or Staphylococcus aureus; (2) acute sinusitis caused by S. pneumoniae or H. influenzae; (3) community-acquired pneumonia due to S. pneumoniae, H. influenzae, H. parainfluenzae, M. catarrhalis, S. aureus, Chlamydophila pneumoniae, Mycoplasma pneumoniae, or Legionella pneumophila; (4) uncomplicated or complicated urinary tract infections (cystitis) caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis; (5) pyelonephritis due to E. coli; (6) uncomplicated urethral and cervical gonorrhea caused by Neisseria gonorrhoeae; and (7) acute uncomplicated rectal infections in females due to N. gonorrhoeae. It is also formulated as a 0.3% ophthalmic solution for the treatment of ocular infections, being the first fourth-generation fluoroquinolone approved for this indication. Gatifloxacin exhibits broad in vitro activity against Gram-positive and Gram-negative bacteria as well as atypical pathogens, acting by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby interfering with DNA replication, transcription, and repair.

InChIKey

XUBOMFCQGDBHNK-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  160738-57-8 逆合成路线 1

ACBXJL896
103460-89-5
ACQVKH312
1184-54-9
ACSOIC371
160738-57-8
来源: SureRoute

2.  160738-57-8 逆合成路线 2

—
—
ACXWKJ871
112811-72-0
ACSOIC371
160738-57-8
来源: SureRoute

3.  160738-57-8 逆合成路线 3

—
—
—
—
ACSOIC371
160738-57-8
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手